EOSE
Eos Energy Enterprises, Inc.
There isn't enough reported data to score EOSE yet.
PSIX
Power Solutions International, Inc.
PSIX's fundamentals are mixed: it turned 15% of its revenue into free cash flow, but earnings per share fell 42%. At 13x earnings, it's trading above its usual 11x. Analysts expect strong earnings growth.
EOSE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
EOSE's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
PSIX Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Strong | |
| Strong |
PSIX's cash flow and balance sheet are currently strong, and its profitability is stable, but its revenue is under pressure.
EOSE PE Valuation
EOSE has no meaningful PE right now: it lost money over the past year.
PSIX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 3.1x | $9.56 | -76% |
| Fair | 10x | $31.91 | -19% |
| Forward | 11x | $39.42 | — |
| Current | 13x | $39.42 | — |
| Expensive | 17x | $52.04 | +32% |
Historical ranges are pointers, not guarantees.
PSIX's PE is in its expensive range at 13x. If earnings grow as analysts expect, today's price would be 11x next year's earnings, in its fair range.
EOSE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect EOSE's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
PSIX Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for PSIX, with profitability improving.
EOSE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2023 | -$2.69 | +$0.85 |
| Q2 2023 | -$3.76 | -$1.00 |
| Q1 2023 | -$3.65 | -$0.86 |
| Q4 2022 | -$3.68 | -$1.32 |
| Q3 2022 | -$3.54 | +$5.19 |
PSIX has the stronger earnings trend. Trailing diluted EPS is down 224% for EOSE versus PSIX down 42%.
PSIX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.55 | +17% |
| Q3 2026 | $3.04 | -42% |
| Q2 2026 | $2.94 | -39% |
| Q1 2026 | $4.43 | +25% |
| Q4 2025 | $4.94 | +64% |
| Q3 2025 | $5.26 | +122% |
| Q2 2025 | $4.81 | +145% |
| Q1 2025 | $3.53 | +172% |
| Q4 2024 | $3.01 | +162% |
PSIX's earnings per share have fallen from their peak: $3.04 over the past year, against $5.26 in late 2025.
EOSE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $82.7M | +171% |
| Q2 2026 | $68.8M | +351% |
| Q1 2026 | $57M | +445% |
| Q4 2025 | $58M | +700% |
| Q3 2025 | $30.5M | +3473% |
| Q2 2025 | $15.2M | +1597% |
| Q1 2025 | $10.5M | +58% |
| Q4 2024 | $7.3M | +9.7% |
EOSE has the edge over PSIX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -96% | +105 points |
| Q2 2026 | -122% | +297 points |
| Q1 2026 | -139% | +367 points |
| Q4 2025 | -140% | +573 points |
| Q3 2025 | -201% | +6044 points |
| Q2 2025 | -419% | +2815 points |
| Q1 2025 | -506% | +117 points |
| Q4 2024 | -713% | -74 points |
EOSE's operating margin was −96% last quarter, up 105 points from the same quarter a year ago, near the top of its range since 2019.
PSIX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $202.1M | -0.9% |
| Q2 2026 | $152.5M | -21% |
| Q1 2026 | $128.6M | -5.1% |
| Q4 2025 | $191.2M | +33% |
| Q3 2025 | $203.8M | +62% |
| Q2 2025 | $191.9M | +74% |
| Q1 2025 | $135.4M | +42% |
| Q4 2024 | $144.3M | +38% |
PSIX's revenue has held roughly level: $202M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +6.3 points |
| Q2 2026 | 16% | -1.3 points |
| Q1 2026 | 8.9% | -9.3 points |
| Q4 2025 | 13% | -4.8 points |
| Q3 2025 | 14% | -2.3 points |
| Q2 2025 | 17% | -6 points |
| Q1 2025 | 18% | +7 points |
| Q4 2024 | 17% | +5.7 points |
PSIX has the edge over EOSE on profitability, with a higher operating margin.
EOSE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$105.1M | -$22.4M |
| Q2 2026 | -$107.4M | -$34.3M |
| Q1 2026 | -$154.8M | -$121M |
| Q4 2025 | -$75.2M | -$19.5M |
| Q3 2025 | -$82.7M | -$28.5M |
| Q2 2025 | -$73.2M | -$40.6M |
| Q1 2025 | -$33.8M | +$10.7M |
| Q4 2024 | -$55.8M | -$10.2M |
EOSE has burned cash in almost every quarter: −$443M over the past year, against −$246M the year before.
PSIX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $38.3M | +2119% |
| Q2 2026 | $55.7M | +281% |
| Q1 2026 | $17.2M | +219% |
| Q4 2025 | -$7.6M | -125% |
| Q3 2025 | $1.7M | -86% |
| Q2 2025 | $14.6M | +1679% |
| Q1 2025 | $5.4M | -63% |
| Q4 2024 | $30M | +398% |
PSIX has the edge over EOSE on cash generation, producing positive trailing cash flow while its opponent burns cash.
EOSE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +63% | +213M shares |
| 1 year | +161% | +341M shares |
| 3 years | +888% | +497M shares |
EOSE has 553M diluted shares, up 161% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
PSIX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +3K shares |
| 1 year | +0.1% | +14K shares |
| 3 years | +0.4% | +101K shares |
| 5 years | +0.7% | +155K shares |
| Available history | +7.2% | +1.5M shares |
PSIX has the edge over EOSE on shareholder dilution, with a more favorable share count trend.
EOSE Net Leverage
EOSE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
PSIX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.7x | Net Cash |
| Q2 2026 | -0.7x | Net Cash |
| Q1 2026 | -0.4x | Net Cash |
| Q4 2025 | -0.4x | Net Cash |
| Q3 2025 | -0.4x | Net Cash |
| Q2 2025 | 0.4x | Very low |
| Q1 2025 | 0.6x | Very low |
| Q4 2024 | 0.8x | Very low |
PSIX has more cash than debt.
EOSE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.5 | Neutral |
| Stochastic | 7.4 | Oversold |
EOSE's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
PSIX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.7 | Neutral |
| Stochastic | 49.7 | Neutral |
PSIX's weekly RSI is 44 (neutral) and its Stochastic is 50 (neutral).
EOSE PE vs Industrials Sector
EOSE has no meaningful PE right now: it lost money over the past year.
PSIX PE vs Industrials Sector
| Metric | PSIX | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 24x | 46% below |
| PE % | 66 | 58 | 8 pts above |
PSIX is trading at 13x earnings, a 46% discount to the Industrials sector's median of 24x.
EOSE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.24 | 19% below |
| 20 week MA | $3.28 | 45% below |
| 50 week MA | $7.01 | 74% below |
| 100 week MA | $7.10 | 75% below |
| 200 week MA | $4.53 | 60% below |
EOSE is in a downtrend: it's below all five of its weekly moving averages, and 60% below its 200-week average.
PSIX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.7 | 12% below |
| 20 week MA | $40.0 | 1.4% below |
| 50 week MA | $54.1 | 27% below |
| 100 week MA | $55.3 | 29% below |
| 200 week MA | $31.2 | 27% above |
PSIX has the edge over EOSE on trend strength, trading above more of its moving averages.
EOSE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.72 | $19.2 | +98% |
| 2021 | $19.2 | $8.57 | -55% |
| 2022 | $8.57 | $1.08 | -87% |
| 2023 | $1.08 | $1.09 | +0.9% |
| 2024 | $1.09 | $5.17 | +374% |
| 2025 | $5.17 | $11.9 | +129% |
| 2026 YTD | $11.9 | $1.81 | -85% |
EOSE's yearly returns have swung widely, from +374% in 2024 to −87% in 2022. It's down 85% so far in 2026.
PSIX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4.25 | $3.26 | -23% |
| 2021 | $3.26 | $2.95 | -9.5% |
| 2022 | $2.95 | $2.92 | -1% |
| 2023 | $2.92 | $2.05 | -30% |
| 2024 | $2.05 | $27.1 | +1220% |
| 2025 | $27.1 | $65.5 | +142% |
| 2026 YTD | $65.5 | $39.4 | -40% |
PSIX has the edge over EOSE on returns for 2026, with the stronger performance.